Company releases

Company announcements

1 B EN RGB
Brain+ announces first day of trading in new shares from the TO 4 warrant exercise and the related directed issue
Read more
1 B EN RGB
Brain+ announces the outcome of its series TO 4 warrant exercise and the decision to carry out a directed share issue to cover guarantor subscriptions
Read more
1 B EN RGB
Brain+ A/S announces additional commitments of DKK 1.4 million in the ongoing TO 4 warrant exercise, which is now covered at 40.4%
Read more
1 B EN RGB
Brain+ A/S announces that its board and management provide commitments to cover 13.7% of the warrants of series TO 4
Read more

News releases

Brain -new-logo-black text-orange
Brain+ unveils new visual brand and website to elevate its Ayla Dementia Care solutions
Read more
1 B EN RGB
Brain+ launches Ayla – your CST Assistant into the UK dementia market
Read more
1 B EN RGB
Ayla – your CST Assistant has been registered in the UK as a certified Medical Device Software for dementia therapy
Read more
1 B EN RGB
Brain+ confirms imminent commercial launch of Ayla – your CST Assistant as a medical device in the UK
Read more
Unlocking the value of Cognitive Stimulation Therapy: a best kept secret

Sign up for our webinar.

Mon, Oct 21, 2024
11:00 pm – 12:00 pm (BST)

Brain+ are delighted to invite you to join us for a webinar focused on the future of Cognitive Stimulation Therapy (CST), aimed at policy makers, commissioners, providers, healthcare professionals, researchers, and innovators in the field of dementia care. (read more)